BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NephU - ECPv6.15.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NephU
X-ORIGINAL-URL:https://nephu.org
X-WR-CALDESC:Events for NephU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210630T120000
DTEND;TZID=America/New_York:20210630T130000
DTSTAMP:20260718T105507
CREATED:20210602T175828Z
LAST-MODIFIED:20210927T144935Z
UID:10108-1625054400-1625058000@nephu.org
SUMMARY:Transplant Considerations For Patients With Polycystic Kidney Disease
DESCRIPTION:Kidney transplantation can improve the quality of life and reduces the mortality risk for patients who have reached kidney failure.1 However\, there are many considerations that a patient undergoes during the transplant evaluation process\, some of which are unique to patients with autosomal dominant polycystic kidney disease (ADPKD). Join us as experts\, Dr Meyeon Park and Dr Simin Goral discuss different factors and choices patients with kidney failure must process during their journey to a kidney transplant. As well as hearing from our peer specialist\, Mr Kevin Fowler\, about his experience during his pre-emptive transplant journey. \n\n\n\nVella\, J. (2019). Kidney transplantation in adults: Patient survival after kidney transplantation.\n\n\n\n*Drs Meyeon Park\, Simin Goral\, and Mr Kevin Fowler are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Dr Jill Green is an employee of OPDC. \n\n\n\n				You must be logged in to register for this event.\nPlease Log In or Join Now\n				\n					Join To View\n					Already A Member? Login\n				\n			\n\n\n\n\n \n\n\n\n\nIf you would like to register for the 6:00 pm to 7:00 pm EDT broadcast\, please click below: \n\n\n\n\nRegister For The 6:00 pm Broadcast\n\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n 			\n 		\n		\n			Jill A Green\, PhD\n			Nephrology Medical Science Director\n		\n 		\n				\n					\n					\nOtsuka Pharmaceutical Development & Commercialization\, Inc.*\n \n				\n				Jill A Green\, PhD\, is a Medical Science Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization\, Inc.  Dr Green received her PhD in biomedical sciences\, with a specialization in biochemical and molecular basis of disease.  She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University\, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital. \nDr Green has been a proud member of the PKD Foundation – Columbus\, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts. \n\n			\n 	\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/transplant-considerations-for-patients-with-polycystic-kidney-disease/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/12/NephU-Webinar-Light-600x400-80-Percent.jpg
END:VEVENT
END:VCALENDAR